title: Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.
abstract: We have examined complement receptors on human umbilical vein endothelial cells (HUVEC) and found that they express complement receptor 1 (CR1, CD35) and complement receptor 4 (CR4, CD11c/CD18), but not complement receptor 3 (CR3, CD11b/CD18). Binding of monoclonal antibodies against CR1 (CD35) and CR4 (CD11c/CD18) to HUVEC was demonstrated by flow cytometry. The presence of the corresponding mRNAs was confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and sequencing of the amplified cDNA fragments. When HUVEC were treated with inflammatory mediators, chemotactic agents or the secretagogue phorbol-12-myristate-13-acetate (PMA), no change in reactivity to CR1 (CD35) or CR4 (CD11c/CD18) monoclonal antibodies was detected on the surface of the cells compared with untreated cells. The presence of CR1 (CD35) and CR4 (CD1c/CD18) on HUVEC indicates that endothelial cells (EC) have the potential to bind C3b and iC3b, respectively, which both mediate biological effects in the course of complement activation.
authors.affiliation: Research Forum, Ullevål Hospital, University of Oslo, Norway. Harald.Langeggen@ulleval.no
authors.forename: Harald
authors.initials: H
authors.lastname: Langeggen
authors.forename: Knut Erik
authors.initials: KE
authors.lastname: Berge
authors.forename: Egil
authors.initials: E
authors.lastname: Johnson
authors.forename: Geir
authors.initials: G
authors.lastname: Hetland
mesh_terms: D000911:Antibodies, Monoclonal; D002630:Chemotactic Factors / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D018836:Inflammation Mediators / Q000494:pharmacology; D016167:Integrin alphaXbeta2 / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D017463:Receptors, Complement 3b / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000031:analogs & derivatives / Q000494:pharmacology; D014471:Umbilical Veins
chemical_list: D000911:Antibodies, Monoclonal; D002630:Chemotactic Factors; D018836:Inflammation Mediators; D016167:Integrin alphaXbeta2; D012333:RNA, Messenger; D017463:Receptors, Complement 3b; C016658:phorbolol myristate acetate; D013755:Tetradecanoylphorbol Acetate